Table 5.
Deterministic heterogeneity: Interactions of attributes with demographics.
| Attribute | Attribute levels | Sex |
Age groups |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Male |
Female |
Young |
Middle aged |
Elderly |
|||||||
| Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | ||
| Vaccine content | Non-Halal | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Halal | 3·722 | 3·152, 4·292 | 4·604 | 3·970, 5·237 | 4·295 | 3·581, 5·008 | 3·722 | 3·152, 4·292 | 2·879 | 2·256, 3·502 | |
| Vaccine Effectiveness | Effectiveness 70% | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Effectiveness 70-90% | 1·959 | 1·687, 2·231 | 1·959 | 1·687, 2·231 | 1·959 | 1·687, 2·231 | 1·959 | 1·687, 2·231 | 1·959 | 1·687, 2·231 | |
| Effectiveness >90% | 3·061 | 2·628, 3·494 | 3·061 | 2·628, 3·494 | 3·594 | 3·017, 4·172 | 3·061 | 2·628, 3·494 | 1·158 | 0·563, 1·752 | |
| Severe side effects of vaccine | Very low | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Low | -0·79 | -0·979, -0·601 | -0·79 | -0·979, -0·601 | -0·442 | -0·719, -0·165 | -0·79 | -0·979, -0·601 | -0·79 | -0·979, -0·601 | |
| Moderate | -1·466 | -1·834, -1·098 | -1·466 | -1·834, -1·098 | -0·747 | -1·184, -0·311 | -1·466 | -1·834, -1·098 | -1·466 | -1·834, -1·098 | |
| High | -1·747 | -2·267, -1·225 | -2·434 | -2·971, -1·897 | -1·747 | -2·269, -1·225 | -1·747 | -2·267, -1·225 | -1·747 | -2·267, -1·225 | |
| Vaccination schedule | Non office hour | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Office hour | -0·18 | -0·296, -0·064 | -0·18 | -0·296, -0·064 | -0·18 | -0·296, -0·064 | -0·18 | -0·296, -0·064 | 0·134 | -0·214, 0·482 | |
| Distance from home to vaccination facilities (continuous scale) | -0·03 | -0·040, -0·020 | -0·03 | -0·040, -0·020 | -0·03 | -0·040, -0·020 | -0·03 | -0·040, -0·020 | -0·03 | -0·040, -0·020 | |
| Attribute | Attribute levels | Presence of health conditions |
Ethnicity |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Yes |
No |
Malay |
Chinese |
Indian |
|||||||
| Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | ||
| Vaccine content | Non-Halal | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Halal | 3·722 | 3·152, 4·292 | 3·722 | 3·152, 4·292 | 3·722 | 3·152, 4·292 | -0·315 | -0·705, 0·075 | -0·541 | -1·266, 0·185 | |
| Vaccine Effectiveness | Effectiveness 70% | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Effectiveness 70-90% | 1·959 | 1·687, 2·231 | 1·959 | 1·687, 2·231 | 1·959 | 1·687, 2·231 | 2·514 | 2·154, 2·875 | 3·044 | 2·293-3·796 | |
| Effectiveness >90% | 3·061 | 2·628, 3·494 | 3·061 | 2·628, 3·494 | 3·061 | 2·628, 3·494 | 3·973 | 3·366, 4·580 | 5·011 | 3·830, 6·192 | |
| Severe side effects of vaccine | Very low | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Low | -0·79 | -0·979, -0·601 | -0·79 | -0·979, -0·601 | -0·79 | -0·979, -0·601 | -0·790 | -0·979, -0·601 | -0·790 | -0·979, -0·601 | |
| Moderate | -1·856 | -2·314, -1·398 | -1·466 | -1·834, -1·098 | -1·466 | -1·834, -1·098 | -2·099 | -2·546, -1·653 | -1·466 | -1·834, -1·098 | |
| High | -2·570 | -3·231, -1·908 | -1·747 | -2·267, -1·225 | -1·747 | -2·267, -1·225 | -2·836 | -3·464, -2·209 | -1·747 | -2·267, -1·225 | |
| Vaccination schedule | Non office hour | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Office hour | 0·108 | -0·115, 0·331 | -0·18 | -0·296, -0·064 | -0·18 | -0·296, -0·064 | -0·180 | -0·296, -0·064 | -0·180 | -0·296, -0·064 | |
| Distance from home to vaccination facilities (continuous scale) | -0·03 | -0·040, -0·020 | -0·03 | -0·040, -0·020 | -0·03 | -0·040, -0·020 | -0·030 | -0·040, -0·020 | -0·014 | -0·030, 0·002 | |
| Attribute | Attribute levels | Region of residence |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Central |
North |
South |
East |
Borneo |
|||||||
| Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | ||
| Vaccine content | Non-Halal | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Halal | 3·722 | 3·152, 4·292 | 3·722 | 3·152, 4·292 | 3·722 | 3·152, 4·292 | 3·722 | 3·152, 4·292 | 1·970 | 1·262, 2·678 | |
| Vaccine Effectiveness | Effectiveness 70% | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Effectiveness 70-90% | 1·959 | 1·687, 2·231 | 1·959 | 1·687, 2·231 | 1·959 | 1·687, 2·231 | 1·959 | 1·687, 2·231 | 1·959 | 1·687, 2·231 | |
| Effectiveness >90% | 3·061 | 2·628, 3·494 | 3·061 | 2·628, 3·494 | 3·061 | 2·628, 3·494 | 3·061 | 2·628, 3·494 | 3·986 | 3·228, 4·743 | |
| Severe side effects of vaccine | Very low | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Low | -0·79 | -0·979, -0·601 | -0·790 | -0·979, -0·601 | -0·149 | -0·635, 0·338 | -0·79 | -0·979, -0·601 | -0·315 | -0·773, 0·143 | |
| Moderate | -1·466 | -1·834, -1·098 | -1·466 | -1·834, -1·098 | -0·707 | -1·346, -0·067 | -1·466 | -1·834, -1·098 | -0·690 | -1·215, -0·165 | |
| High | -1·747 | -2·267, -1·225 | -1·747 | -2·267, -1·225 | -0·642 | -1·419, 0·135 | -1·747 | -2·267, -1·225 | -0·823 | -1·607, -0·039 | |
| Vaccination schedule | Non office hour | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Office hour | -0·180 | -0·296, -0·064 | -0·180 | -0·296, -0·064 | -0·180 | -0·296, -0·064 | -0·180 | -0·296, -0·064 | -0·180 | -0·296, -0·064 | |
| Distance from home to vaccination facilities (continuous scale) | -0·030 | -0·040, -0·020 | -0·020 | -0·031, -0·009 | -0·020 | -0·030, -0·005 | -0·030 | -0·040, -0·020 | -0·030 | -0·040, -0·020 | |
| Attribute | Attribute levels | Education level |
Income level |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Low |
High |
Low |
Moderate |
High |
|||||||
| Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | Coefficient (SE) | LCB, UCB | ||
| Vaccine content | Non-Halal | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Halal | 3·722 | 3·152, 4·292 | 4·269 | 3·647, 4·891 | 3·722 | 3·152, 4·292 | 3·722 | 3·152, 4·292 | 3·722 | 3·152, 4·292 | |
| Vaccine Effectiveness | Effectiveness 70% | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Effectiveness 70-90% | 1·959 | 1·687, 2·231 | 1·959 | 1·687, 2·231 | 1·959 | 1·687, 2·231 | 1·959 | 1·687, 2·231 | 1·959 | 1·687, 2·231 | |
| Effectiveness >90% | 3·061 | 2·628, 3·494 | 3·061 | 2·628, 3·494 | 3·061 | 2·628, 3·494 | 3·061 | 2·628, 3·494 | 3·061 | 2·628, 3·494 | |
| Severe side effects of vaccine | Very low | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Low | -0·79 | -0·979, -0·601 | -0·79 | -0·979, -0·601 | -0·79 | -0·979, -0·601 | -0·79 | -0·979, -0·601 | -0·79 | -0·979, -0·601 | |
| Moderate | -1·466 | -1·834, -1·098 | -2·082 | -2·439, -1·726 | -1·466 | -1·834, -1·098 | -1·466 | -1·834, -1·098 | -1·466 | -1·834, -1·098 | |
| High | -1·747 | -2·267, -1·225 | -2·919 | -3·477, -2·361 | -1·747 | -2·267, -1·225 | -1·747 | -2·267, -1·225 | -1·747 | -2·267, -1·225 | |
| Vaccination schedule | Non office hour | Reference | - | Reference | - | Reference | - | Reference | - | Reference | - |
| Office hour | -0·18 | -0·296, -0·064 | -0·18 | -0·296, -0·064 | -0·18 | -0·296, -0·064 | -0·18 | -0·296, -0·064 | -0·18 | -0·296, -0·064 | |
| Distance from home to vaccination facilities (continuous scale) | -0·03 | -0·040, -0·020 | -0·03 | -0·040, -0·020 | -0·03 | -0·040, -0·020 | -0·03 | -0·040, -0·020 | -0·03 | -0·040, -0·020 | |
Note: SE= Standard error; LCB= Lower Confidence Bound; UCB= Upper Confidence Bound. If the utility values are the same, there was no preference heterogeneity detected across the groups.